An immune system for the city: A cluster-randomized trial of a new paradigm for surveillance and control of disease vectors Authors: Michael Z. Levy, Laura D. Tamayo, Carlos E. Condori-Pino, Claudia Arevalo-Nieto, Ricardo Castillo-Neyra, Valerie A. Paz-Soldán, Audrey Lenhart, Jennifer K. Peterson, Audrey Lenhart, Jennifer K. Peterson, Audrey Lenhart, Jennifer K. Peterson, Audrey Lenhart, Jennifer K. Peterson, Audrey Lenhart, Jennifer K. Peterson Published: 2026 ABSTRACT Vector-borne pathogens continue to emerge, kill and harm humans with unrelenting regularity. Conventional strategies for controlling insect vectors grew out of the military; communication is hierarchical, responses unilateral, and regulation predetermined. We developed an alternative approach, modeled after the adaptive immune system, and compared the approaches through a cluster-randomized trial in the context of an ongoing urban Chagas disease vector control campaign in Arequipa, Peru. Clusters consisted of pre-defined geographic jurisdictions of health facilities, and averaged 2,271 households. Thirty clusters were assigned to the immune arm, and thirty to the conventional arm, balancing on antecedents related to the probability of vector infestation. Following delays, the trial initiated in October 2021. We report here early results from a pre-planned interim analysis scheduled for March 2023. In the immune arm 23 infested households were discovered and confirmed in 10 separate foci; in the conventional arm only 5 infested households were discovered and confirmed, and all were from the same focus. The immune approach was adaptive, and more effort was expended upon confirmation of an infestation (1085.2 person days in the immune arm vs 864.2 in the conventional; Rate ratio 23/1085.2:5/864.2 = 3.66 [1.49 - 10.60], p-value = 0.0038). Vector surveillance approaches modeled after the immune system are a potentially more effective alternative to conventional approaches, especially to control vector borne diseases in cities and other complex environments. Introduction The difficulties faced by a community when trying to control a dangerous insect are in many ways analogous to those faced by the body when attacked by a pathogen. Through evolution, mammals have developed a complex and interlocking defense against invaders—an immune system well-honed to detect and control infections. The adaptive immune system relies on communication among autonomous entities to recognize pathogens and recruit effector cells [1]; it includes a combination of systemic and local responses to remove pathogens; and, most amazingly, tightly regulates these responses and creates memory to improve them in the future [2]. Conventional strategies for vector control, by contrast, grew out of the military; with hierarchical communication, unilateral responses, and predetermined regulation [3]. Despite their ubiquity, top-down control campaigns have rarely been challenged, formally, by alternative approaches. We conducted a cluster-randomized trial evaluating a new paradigm for the control of dangerous insects patterned after the adaptive immune system against a conventional top-down system in an ongoing Chagas disease vector control program in the city of Arequipa, Peru. Here we report the early results from a pre-planned interim analysis. Chagas disease, caused by the parasite Trypanosoma cruzi, is one of the principal infectious causes of morbidity and mortality in the Americas [4,5]. Since 1991, Triatoma infestans, the principal vector of T. cruzi in South America, has been the target of an elimination program known as the Southern Cone Initiative. This initiative, formalized in the early 1990s during a period of return to democracy in many countries in the region, nevertheless retained conventional top-down vector control approaches that had proven successful under more authoritarian regimes. By many measures [6,7], the initiative has been a tremendous success, with Chile [8], Brazil [9], Uruguay [10], and Paraguay [11] achieving disruption of transmission of T. cruzi by T. infestans. Peru did not initially join the Southern Cone Initiative, and control efforts in the country lagged for many years [12]. T. infestans is limited to Southern Peru, where it infested Arequipa, a regional capital of over one million inhabitants [13]. Initially with support from the Canadian International Development Agency and technical support from the Pan American Health Organization, the Peruvian Ministry of Health conducted insecticide treatment of over 80,000 houses, preventing significant mortality and morbidity [14,15]. The campaign, like many conventional campaigns [16,17], consisted of three phases: the preliminary planning phase which served to define the geographic areas in need of control [18], the attack phase [19] during which brigades of vector control technicians applied pyrethroid insecticides to domestic and peri-domestic areas of all participating homes (twice at a target 6-month interval), and the post-spray surveillance phase, in which households are monitored for insects through a combination of passive and active methods. The attack phase in Arequipa lasted from 2003 to 2018 and proceeded on a district-by-district basis. Serological studies conducted contemporaneously with the attack phase revealed a range of infection prevalence from 7.6% in a peri-rural district (La Joya) [20], to ~5% in peri-urban districts [13], 2.3% in more central districts (multiple districts) [21] and 1.4% (Mariano Melgar) [22]. Districts entered the surveillance phase in a rolling manner, six months following completion of insecticide application. Initially, post-spray surveillance activities were mostly limited to passive surveillance, with occasional active search for infested households when personnel were available [23,24]. A series of data-driven surveillance schemes were piloted in multiple districts of the city [14,25,26]. These studies included search for the insect in over 8,000 households based on data collected during the attack phase and new data that accumulated during the surveillance phase. Only three infested households were detected through these efforts. Materials and methods Intervention design The immune approach: We adapted cell-level components of the immune system to analogues at the scale of landscapes, incorporating these into the ongoing Chagas disease vector surveillance activities. Our analogy is described fully in Fig 1. The conventional approach is an augmented version of standard practice, including traditional communication techniques and passive surveillance, along with state-of-the-art, though top-down, active surveillance methods. We outline the key ways in which the two approaches diverge, ideologically as well as methodologically, below. Analogies for vector control a) the conventional, military analogy, b) the immune system analogy. CHW = Community Health Worker. The figure incorporates icons sourced from https://bioart.niaid.nih.gov and openclipart.org under the CC BY 4.0 license. Specifically, the “House” icon was taken from openclipart.org/74425; the “T-cell” icon from https://bioart.niaid.nih.gov/bioart/509; the “Simple avatar icon” from openclipart.org/307452; the “inspector” icon from https://openclipart.org/image/800px/163837; the “Hospital” icon from openclipart.org/314202; and the “antigen-presenting cell” icon from https://bioart.niaid.nih.gov/bioart/284. The triatomine icon was designed by our team. Reporting The immune system is extraordinarily egalitarian. Any of a large population of cells may present an antigen and trigger the system to act, thereby catching an invading pathogen early, before it spreads. Under the conventional system, infested households are considered, not as antigen-presenting cells that will seek the attention of the surveillance system, but as the ‘enemy’, which will avoid it. Public health officials worry homeowners might be hiding infestations, or falsely reporting infestations in order to obtain free insecticide treatment for other nuisance insects. The lack of trust manifests in the regulations for both reporting and search (the latter is discussed below). For reporting, if a homeowner finds a triatomine they are required to capture it [27] and bring it to a primary-level health facility for identification. The requirement produces a barrier for those homeowners who are hesitant or unable to trap insects [28]. It also presents logistical challenges as the health facility must have staff on hand to identify the insect, or to get the insect to the right person in a timely manner. Moreover, efficient data management systems are necessary to convey the identification up the chain of command to the central vector control office. Additional delays may occur in the central office where the authority and resources to program treatment of the infested house sits. In the immune arm, we dropped the requirement to bring an insect to the health post for identification. Instead, we accepted reports by phone call, social media, text message, and Whatsapp through an integrated system we publicized as ‘AlertaChirimacha’ [29], named after the local name for the triatomine, Chirimacha. We requested, but did not require, photographs of the insects. All reports were confirmed by trained study staff. Search The immune system is decentralized; T-cells guide their own movements, aided by information imparted to them through cytokines, in much the same way that animals search their environment for food [30]. There is no control center; no physiological structure directs the T-cells. Conventional vector surveillance paradigms, by contrast, are top-down, with a central authority directing the activities of vector control personnel. We used two apps, both based on the same spatio-temporal risk models [25]. The conventional app assigned households for inspection to personnel, providing alternates as needed. The immune app, called VectorPoint, provided risk estimates but allowed inspectors to use their own judgment when searching their areas for insects [14,26]. In both arms we did not use a strict person-hour time limit for search, due to the immense variation in the size of houses in the study area. Interaction with homeowners T-cells elicit information from the somatic cells they surveil, they do not enter them. Under the conventional system, vector control personnel are instructed to enter and fully inspect the premises of the households they are assigned. The requirement stems, in part, from the suspicion that householders may be hiding infestations that could be uncovered through a thorough inspection. In the immune arm we did not require vector control personnel to enter households. Instead, they were instructed to visit houses, speak to residents about Chagas disease and triatomines, and provide materials indicating how these could be reported via AlertaChirimacha. Inspectors offered to inspect households if a resident feared they might have an infestation, or if they were unable to check for insects themselves. Response The conventional arm of our trial continued the practice of inspecting the immediate neighbors of each household found to be infested with triatomines. In the immune arm, the system was activated, temporarily, following confirmation of an infested household. Vector technicians working in nearby areas were brought to assist in controlling the focus of infestation (200 m around the index house), the way immune cells are recruited to the site of an infection. Along with the original technician, they distributed flyers to all households and placed posters in local shops. In addition, Facebook posts were targeted to the area for 10 days (the radius of Facebook’s targeted posting is defined by the number of users in the area, but was typically around 1 km) and verbally by including the name(s) of the neighborhood(s) affected. The posts encouraged residents to inspect their homes for triatomines and report any suspected bug, or its traces (feces or exoskeletons), via WhatsApp, text message or phone call. The Facebook page and posts were publicly accessible. LDT and CECP actively monitored the posts and responded to comments or questions. Comments received on the posts were addressed through public replies, while reports of potential infestations were managed through direct communication with users. If additional infested houses near the original focus were found, the radius was expanded around the new infestation, and additional inspectors recruited as necessary. A follow-up post was released on Facebook on days 10 and 30 after the initial post. Subsequent posts informed neighbors that more houses had been found positive and asked them to stay alert to the presence of triatomines and report them, if found. Once all households in the affected area had been visited by technicians, those who had been recruited to the site were allowed to return to their own catchments. We posted a ‘downregulation’ message on Facebook once all infested houses were treated and 30 days had passed with no additional infestations. This message explained that the affected houses had been treated with insecticide and the insects were controlled. Deviations from the protocol due to ‘Immune suppression’ during COVID-19 The original protocol included significant roles for community health workers (CHWs). In the conventional arm, these individuals were meant to visit their neighbors regularly to ask if they had chirimachas and, in the case of an affirmative, report the household to the corresponding health center. In the immune arm, the role of community health workers was patterned after that of CD4 + helper T-cells. They were meant to visit their neighbors, and, in the case of a neighbor reporting an infestation, communicate, via Whatsapp, directly to the vector control technician. The technician would then come to the site and activate the response, if necessary, as described above. Most importantly the community health worker was meant to’clonally expand’ by training others in their neighborhood to serve as community health workers, temporarily, while the immune system was activated. These secondary community health workers would then form part of the memory of the system, available for re-activation if another infestation were to appear in the area in the future. During the pandemic, the community health worker system broke down and these planned activities were dropped. Trial design We divided the area of the city under vector surveillance into 60 surveillance clusters, following existing Ministry of Health catchments. In order to balance these clusters (30 in the immune and 30 in the conventional arm) we first created pairs using a non-bipartite matching algorithm (R package “nbpMatching”) [31] then balanced the assignment of members of these pairs to the arms of the trial based on three criteria that we have previously found to be indicators of the risk of infestation [24]: the total number of households, the number of infested houses detected in prior surveillance activities, and the years since insecticide application during the attack phase. The average sizes of clusters in the immune and conventional arms were 2275.7 and 2266.7 households, respectively. In the immune arm an average of 1267 houses had been treated during the attack phase in each catchment, and an average of 98.5 were found to be infested at the time of treatment. In the conventional arm an average of 1143.8 households were treated in each catchment, and the average number of infested households was 94.6 (Table 2). The trial is registered in socialscienceregistry.org (trial 10985). 10.1371/journal.pntd.0014464.t001Table 1Trial at a glance.Trial componentDescriptionStudy periodPlanned: March 2020–February 2025; interim analysis planned for March 2023. Actual: October 2021–March 2023.Study designCluster-randomized trial.Sample sizeSixty clusters were included, with 30 clusters per arm. The mean number of households per cluster was 2275.7 in the intervention arm and 2266.7 in the conventional arm.RandomizationTrial arms were balanced by number of households, time since treatment during the attack phase of the control campaign, and prevalence of infestation detected during the attack phase.ClustersClusters were defined as the geographical jurisdictions of primary care health facilities, according to the local Ministry of Health.OutcomesPrimary outcome: Number of households with confirmed presence of Triatoma infestans, as verified by study staff. Secondary Outcome: Number of foci of infestation (infested households within 200 m of each other). Trial at a glance. 10.1371/journal.pntd.0014464.t002Table 2Baseline characteristics of surveillance clusters in each arm as measured during the attack phase of the Chagas disease vector control campaign in Arequipa, Peru (white). Interim results from year 3 of a head-to-head trial of the Immune and Conventional surveillance systems (grey).Cluster Pair for BalancingImmuneConventionalYear of attack phasePositive during attack phaseTreated housesTotal HousesFoci detected# of infested houses detectedYear of attack phasePositive during attack phaseTreated housesTotal HousesFoci detected# of infested houses detected1201211526263265122012831935290100220117212541635002011681113157900320078986518740020091151015210600420073131615770020072684413770052011142130417600020121601061137600620125072727600020121022108271800720096398248200200949925248300820073041551223100200742316151655009201143032044716112007193131339870010200714152124700200727742103200112015339691484002012001188001220095410821280002009566071215001320092871768205613200926416571968001420121655324920020126117258300152005196287232911420062492083309500162014618418740020145015022106001720055810101023112007105108411090018201210822654194282014422217437715192007117119912330020071028591181002020052492606263900200717510172405002120079213992673002007611629286000222015121088533400201569148367340023200957103331211120120263871002420141413025352911201566176136420025201552251760002015215791740002620071391316149112200712614431560002720127114411699002012871516177700282006226492098002005396531658002920053783898300200537977983003020053924710020093643273500 Mean 98.5 1267 2275.7 94.6 1143.8 2266.7 TOTAL 2956 38011 68272 10 23 2837 34313 68001 1 5 The rate of uncovering and confirming infestation was significantly higher in the immune arm (23/1085.2 person days) than the conventional (5/864.2 person days); (Rate ratio = 3.66 [95% CI: 1.49 - 10.60], p-value = 0.0038, Miettinen-Nurminen test). In the Poisson regression for matched clusters, the per-household rate by which the immune arm uncovered confirmed infestations was 2.97 times that of the conventional arm, (95% CIs 1.21 - 8.89], p-value = 0.029). Baseline characteristics of surveillance clusters in each arm as measured during the attack phase of the Chagas disease vector control campaign in Arequipa, Peru (white). Interim results from year 3 of a head-to-head trial of the Immune and Conventional surveillance systems (grey). The rate of uncovering and confirming infestation was significantly higher in the immune arm (23/1085.2 person days) than the conventional (5/864.2 person days); (Rate ratio = 3.66 [95% CI: 1.49 - 10.60], p-value = 0.0038, Miettinen-Nurminen test). In the Poisson regression for matched clusters, the per-household rate by which the immune arm uncovered confirmed infestations was 2.97 times that of the conventional arm, (95% CIs 1.21 - 8.89], p-value = 0.029). The primary outcome of the trial was the presence of triatomine insects in a household. All instances of insects in households were confirmed by trained study staff in both the immune and conventional arms, and regardless of the mode by which the insects were discovered (active or passive surveillance). A secondary outcome was the number of foci of infestation, where all infested households within 200m of each other were considered a focus. We compared the ratio of the number of confirmed infestations detected in each arm and the person days of active search. Although not specified for the interim analysis, we also ran a Poisson regression for matched count data, with an offset of person days in each cluster, and a random effect on the matched pairs. Results The immune approach uncovered 23 infested households, ten from the initial detections or reports and an additional 13 during the activation of the system in the affected areas. The ten initially detected came from nine separate clusters. Five were initially reported through the AlertaChirimacha system (via Facebook or Whatsapp). Three were uncovered through active search by vector control technicians, and two were reported to health posts. The conventional approach uncovered a total of five households in a single cluster; one household brought an insect to a health post and the remaining four were immediate neighbors to the index house (Fig 2; Table 2). Infestations detected, by modality of discovery of the index household, under the immune and conventional surveillance arms. Immune modalities: AlertaChirimacha includes reports via Whatsapp, Facebook & text. Autonomous search includes inspections of households and visits conducted with the Vectorpoint application. Reports to health posts, with or without an insect. Conventional Modalities include Facebook posts to the whole city, Search of households assigned through the conventional app (Bluepoint), and reports to the Health posts with an insect. The amount of effort differed between the two arms, mainly due to the activation of the immune arm following confirmation of infested households. In the immune arm, 835.2 person days were expended by technicians visiting households guided by the Vectorpoint app. An additional 202 person days were expended in the adaptive response initiated around the 10 index infestations, and insecticide application to the 23 infested households and immediate neighbors took 48 person days, for a total of 1085.2 person days (S1 Table). In the conventional arm, technicians spent 855.2 person days inspecting households assigned to them via the conventional app. No infested households were detected through the active search. One infested household was reported to the health post. One additional day was necessary to inspect the neighbors of the index house, and 8 person days were expended in indoor residual insecticide application to infested households and their immediate neighbors for a total of 864.2 total person days of effort (S1 Table). Discussion We challenged the conventional vector control paradigm, formally, against an alternative approach inspired by the adaptive immune system, and the new intervention significantly outperformed the old. Even when fortified with a dozen years of prior data, computational power, and spatial models rarely available to vector control agencies, and the same experienced staff as the immune arm, the conventional protocols only succeeded in uncovering a single focus of vector infestation of five infested houses. Over the same period, the immune arm uncovered 23 infested households in 10 foci spread across nine sectors of the city. Urban vector control requires surveillance and control at various scales, as insects spread among houses, blocks, neighborhoods, and cities. The dream of conventional control has long been scalability– the ability to establish a set of protocols that, in the words of Anna Tsing, ‘can expand–and expand, and expand–without rethinking basic elements’ [32]. Such sentiments are common in the expansion of demonstration projects into large programs [33], and, in the early planning of the Southern Cone Initiative to eliminate Triatoma infestans, in the focus on normalization of strategies across member states [34]. The immune system always works across scales. For the most part, the same system that protects a mouse also protects a moose–but it is not scalable, it cannot be effortlessly ported from one place to another, nor expanded over ever-larger geographies. Our protocols in the immune arm allowed technicians to make decisions based on information that would never fit into a statistical model. Such freedom is critical: as the insects are driven towards elimination the predictable infestations are detected and eliminated, leaving behind the idiosyncratic. The immune arm also relied heavily on personal communication and relationships–whether through AlertaChirimacha or door-to-door communication–which cannot be easily scaled. The need for such tailoring of vector surveillance and control is increasingly acknowledged in Chagas disease control [34,35], and more broadly, calls for normalization have been replaced by calls for greater attention to local ecologies, geographies, and politics [36]. Descriptions of the immune system itself are rife with analogy and metaphor. T-cells and pathogens were once described ‘at war’ with one another [37], and later divided into ‘self’ and ‘nonself’ as a nation with a border, one side of which is in need of protection from the other [38]. The self/nonself analogy has fallen out of favor with increased recognition of the importance of microbiota–a slew of organisms which are not easily, nor consistently, assigned as self or foreign [39]. Understanding of the immune system, and metaphors used to convey that understanding, will continue to evolve, and re-conceptualizations may lead to new ideas about how to control vectors and other disease agents. For Chagas disease vector surveillance, community reporting is often more sensitive than active search by trained personnel [40,41]. In the immune arm, vector control personnel did not insist on entering homes, but rather focused on communication and dissemination of materials to facilitate reports. The conventional approach relies on quotas—a certain number of homes must be searched. For the immune approach to be formally adopted, the quota system, which sits within a framework of pay for performance [42–44], would need to be greatly modified or de-implemented. Quotas have a terrible history in Peru—sterilization programs were enacted on a quota system, leading to widespread abuses of women in the 1990s as health personnel conducted sterilizations by force, or without proper consent, to reach quotas [43,45–47]. The quotas for entering and inspecting homes are less nefarious, but still lead to inefficient and irrational behaviors. Our study had several limitations. Our protocol originally relied heavily on community-based approaches. Community Health Workers were to be the CD4 + T-helper cells, monitoring their neighborhoods and’clonally expanding’ by training additional community health workers upon detecting a vector. Perhaps, had COVID-19 and the related lockdowns not prevented the involvement of community health workers, they could have played a pivotal role in the new system. We shifted our planned communication and clonal expansion from CHWs to social media. In doing so we introduced additional contamination into our study design, as we were not able to target social media posts on a consistent spatial scale around an infestation, and, of course, could not prevent the posts from propagating into areas assigned to the conventional arm. Indeed, the Ministry of Health reposted our posts regularly. While we were not able to prevent this contamination, we may have lessened it by targeting our posts by including the names of the neighborhoods affected. The contamination would have biased our results toward the null. The formalism of a randomized trial also broke down during the pandemic. The interim analysis we present here was planned for the end of the third year of the trial, and we have conducted it as pre-specified at the end of the third year. But we have less than three years of data on hand. We have presented here promising results on a new surveillance system, modeled after the mammalian immune system, to control a single insect in a city. But the immune system does not deal with one pathogen at a time, and cities certainly do not deal with infectious agents in isolation. The real power of the analogy may be revealed as it is expanded to address multiple competing threats. To do so may require de-implementation of the old conventional systems to free up resources for a more adaptive and flexible response. It remains unclear whether such a major change in approach will be palatable to control agencies, but the potential is great. Supporting information Timeline of field implementation and workdays for active surveillance categorized by cluster. period and number of days of active, door-to-door surveillance in each cluster. Pair-level records are followed by totals for each arm. (DOCX) Spanish version of the manuscript. (DOCX) 25 Mar 2026 -->PNTD-D-26-00072-->-->An Immune System for the City: A Randomized Trial of a New Paradigm for Surveillance and Control of Disease Vectors-->-->PLOS Neglected Tropical Diseases-->-->Dear Dr. Levy,-->-->Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->-->Please submit your revised manuscript by May 24 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.-->-->Please include the following items when submitting your revised manuscript:-->-->* A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.-->-->* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.-->-->* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.-->-->If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.-->-->We look forward to receiving your revised manuscript.-->-->Kind regards,-->-->Jennifer K. Peterson-->-->Academic Editor-->-->PLOS Neglected Tropical Diseases-->-->Audrey Lenhart-->-->Section Editor-->-->PLOS Neglected Tropical Diseases-->--> Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 -->-->Journal Requirements: -->--> -->-->We noticed that you used the phrase 'unpublished data' in the manuscript. We do not allow these references, as the PLOS data access policy requires that all data be either published with the manuscript or made available in a publicly accessible database. Please amend the supplementary material to include the referenced data or remove the references. -->-->Reviewers' comments: -->-->Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: The objectives, study design, population, sample size and analyses are all adequately described with the exception of a few comments I've included below. There are no ethical or regulatory concerns. Reviewer #2: See Summary below. ********** Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: Analysis and results are clear, match the analysis plan with an unavoidable exception which is thoroughly described. I have a suggestion for improving one Figure, outlined below. Reviewer #2: See Summary below. ********** Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: the conclusions are supported and the discussion is excellent. Public health relevance is addressed. Reviewer #2: See Summary below. ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: Major comments 1. I’d recommend editing the figure (which is central to understanding the design) to make the surveillance components (CHWs, cell phone alert system, vector control technician) more prominent, e.g. bolded larger font, compared to the immune system analogues (antigen presenting cells, CD4+ Th cells, etc). This would be in line with panel A and would highlight the real world components. 2. If I understand the text correctly, an infested house was defined as demonstration of vectors either by the householder or the vector tech for the conventional arm but could be defined solely by the householder reporting infestation for the intervention arm. Am I reading that correctly? Was there a component of ground-truthing (that is, some kind of confirmation of vector presence in proportion of reportedly infested houses)? Please clarify these points. 3. In a related doubt, I am not sure I entirely understand the roles played by the vector tech in the intervention arm – did they perform house searches only when asked by householder? How many of those were initiated? It would be useful in the description of the systems to be explicitly list their roles under each arm. 4. Section headed “Response” last 3 lines. Were these facebook pages open to all? Were vector techs told to monitor the page at some interval while activated? 5. “Immune suppression during covid-19” You might discuss the adaptability of the novel surveillance system as a potential strength and how to anticipate and maximize its utility. 6. Discussion: I can see clearly how the immune system model of surveillance might be applied to household insect infestations such as bed bugs, but less clearly for other disease vectors, even those where vector population control plays a significant role (tsetse, simulium). Could you comment more specifically on the kinds of surveillance adaptations that might be applicable for other vectorborne diseases? Minor comments 7. Section headed “Intervention design”: I had to read this sentence “we adapted aspects of the immune system from the scale of cells to that of landscapes” several time to understand it. Perhaps clearer to say something like “we adapted cell-level components of the immune system to analogues at the scale of landscapes…” 8. Section headed “Response”, 3rd line. If the definition of an infested house could be based solely on householder response, you may want to replace “detection” with “report”. 9. Figure 2: I realize the Ns are too small to assess this, but I wonder if the large size of 2 of the 3 clusters identified by health post report in both arms together, compared to the cluster sizes detected by the other methods reflects low sensitivity for the health post method (i.e. it generally picks up large clusters, not small ones). Probably too speculative to say anything in this paper, but perhaps when you have more data you could revisit this question. Reviewer #2: See Summary below. ********** Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: This manuscript presents the design and preprogrammed interim evaluation of a surveillance system for household triatomine infestation modeled by analogy on the mammalian immune system. This is, as far as I know, an entirely original way of conceptualizing a surveillance system. While its direct applicability to other disease vectors is likely limited, the creativity of its novel design may well aid in developing novel designs for other vectors, and vector-borne and other diseases in the latter stages of elimination programs. Reviewer #2: Levy et al. conducted a cluster-randomized field trial to test the efficacy of two interventions during the surveillance phase in the city of Arequipa, Peru: the conventional top-down approach used by vector control programs across Latin America, and an innovative approached patterned after the workings of the immune system. The analogy is nice; the size of the trial and amount of field work daunting, and the preliminary outcomes worthy of being reported. In the last sentence of the Abstract, the authors provided a tentative conclusion: “Vector surveillance approaches modeled after the immune system may be more effective than conventional approaches, especially in cities and other complex civilian environments.” However, in the first paragraph of the Discussion conveys a different notion: “… the new intervention quickly outperformed the old.” It may be so (I wouldn’t be surprised at all), but for an interim analysis (as the authors mention) and an outcome measure based on the overall number of infested houses detected relative to the overall search (detection) effort invested, I would suggest a more cautious stance. The trial used a matched-pair design which the (interim) analysis should respect. There are guidelines for reporting the outcomes of randomized clinical trials. I was slightly puzzled by the lack of basic information in the paper; for example, when was this trial conducted, and more specifically, what is the duration of the follow-up? How was the sample size decided? Cluster size? Power? After reading the section on infestation assessment a couple of times, it is not clear to me who and how were the infestations detected in the “immune” arm; were homeowner reports with no need to hand in a triatomine sufficient to declare a house infested? There is also mention of “inspectors” playing a role in the “immune” arm, but it is not clear to me whether they were meant to corroborate infestations or they just searched for triatomines wherever they felt it was justified. In the conventional arm, did the inspectors search all the houses at least once over the study? Specific comments Title Should include “…cluster-randomized trial” Abstract Lacks standard information for cluster-randomized trial such as the number of clusters, average number of households included in each arm, average duration of follow-up. Introduction Looks too short. Why not include the information on the study system (the three paragraphs) in the Introduction? Can you provide estimates for the prevalence of human infection with T. cruzi and house infestation rates at different time points? Methods Intervention design. As both arms include an intervention, following your terminology, using “immune” and “classic” or “vertical” or “conventional” throughout would be clearer than intervention and control arms. Were all actions performed concurrently in both arms? What is the timeline of the onset of interventions and other study components? How did you establish the number of clusters in each study arm? Under Reporting, the conventional system required that homeowners produced some proof of infestation whereas the immune system did not. This is important and it seems to have been played down throughout the text. Under Search, how were the inspections performed? Search effort, number of people, supervision? This is key to outcome assessment. Under Interaction with homeowners, you stress again the suspicion side of the story, probably an excessive emphasis, perhaps you have evidence on this respect, a reference? Home searches for triatomine bugs require an interaction with homeowners and consent, hence they are not independent processes. Under Response, “vector technicians were recruited from nearby areas”. Are these people as qualified as vector control personnel or are they neighbors willing to help? Perhaps “technicians” is misleading depending on experience, training support etc. You also use “original technicians”: are these employees of health services? A few sentences below you mention “inspectors”; better be consistent and explain the affiliations of each of these actors. Last sentence before “Deviations…” is unfinished. Under Deviations…, you mention community health workers of two types, let’s say primary and secondary CHW. The text is sometimes unclear to which of them you refer to. Were they volunteers? Did they have any training? In reference to the three-year follow-up you mention elsewhere, how long did their effective participation last? Under Trial design, I suspect “catchment” is equivalent to “cluster”. If so, I’d suggest that you make the equivalence explicit and stick to one term. It’s nice that you provide the average number of infested houses in each catchment. Can you provide a measure of precision? Results Figure 2 caption. Revise the wording of the last sentence. Paragraph immediately before Table 1 captions: no homeowner report of infestation? Last paragraph of Results: please check the use of Fisher’s exact test for comparison of two rate ratios, this may not be right. Discussion First paragraph: why “quickly”? The Results section did not provide data on the performance of both interventions over time. Use of “intervention arm” may be slightly misleading. Last sentence conveys essential information on trial outcomes: the 5 infested houses in the conventional arm had triatomines found, whereas the 23 infested houses in the “immune arm” was based on homeowner reports with no delive of a bug? Third paragraph: for those readers not familiar with triatomine bugs, please explain what “idiosyncratic” means here. Limitations first paragraph. Which type of CHW are you referring to? Below you state that they did not play a pivotal role because of covid-19 and the related lockdowns. Can you provide a rough estimate of how long were they involved along the follow-up? This sentence conveys the notion that their participation was marginal, not clear to me. At the end of the third paragraph of limitations, you state “But we have less than three years of data on hand.” Thank you for being transparent. This issue appeared before. How long is the duration of the follow-up you are reporting? Is it the same for all clusters? Final paragraph is excellent. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No -->-->[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]-->-->Figure resubmission: -->-->-->While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.-->--> After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.-->-->-->Reproducibility: -->-->To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols--> 20 May 2026 Submitted filename: Response to Reviewers (1).pdf 12 Jun 2026 Dear Dr. Levy, We are pleased to inform you that your manuscript 'An Immune System for the City: A Cluster-Randomized Trial of a New Paradigm for Surveillance and Control of Disease Vectors' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Jennifer K. Peterson Academic Editor PLOS Neglected Tropical Diseases Audrey Lenhart Section Editor PLOS Neglected Tropical Diseases Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-4304-636XX Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases orcid.org/0000-0003-1765-0002 *********************************************************** p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #2: All criteria for acceptance were met. ********** Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #2: All criteria for acceptance were met. ********** Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #2: All criteria for acceptance were met. ********** Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #2: All criteria for acceptance were met. ********** Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #2: The authors' revisions are completely satisfactory and the manuscript appears in very good shape for publication. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Dear Dr. Levy, We are delighted to inform you that your manuscript, " An Immune System for the City: A Cluster-Randomized Trial of a New Paradigm for Surveillance and Control of Disease Vectors," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases